Centre for Cardiovascular Innovation, St Paul's Hospital, Vancouver, BC, Canada and Vancouver General Hospital, Vancouver, BC, Canada.
Cardiovascular Translational Laboratory, Vancouver, BC, Canada and Providence Research & Centre for Heart Lung Innovation, Vancouver, BC, Canada.
EuroIntervention. 2023 Nov 17;19(9):757-765. doi: 10.4244/EIJ-D-23-00308.
When a balloon-expandable transcatheter heart valve (THV) is chosen to treat a failed balloon-expandable THV, there is a risk of underexpansion with a potential impact on performance.
We aimed to assess the impact of pre- and post-dilatation on the expansion of balloon-expandable THVs after redo-transcatheter aortic valve implantation (TAVI).
Redo-TAVI was performed on the bench with a 23 mm SAPIEN 3 (S3) implanted within a 23 mm SAPIEN XT (SXT) or a 23 mm S3, both of which served as the "failed" THVs. Pre- and/or post-dilatation was performed using a 23 mm non-compliant TRUE balloon. Expansion of the index and redo-THVs were assessed before and after pre-/post-dilatation using microcomputed tomography (micro-CT), and THV hydrodynamic testing was conducted.
Without pre- or post-dilatation, the S3 was underexpanded, for all combinations, particularly in the mid-portion of the THV (18.6 mm and 19.7 mm representing 81% and 86% of the nominal diameter inside the SXT and S3, respectively). Pre- and post-dilatation had an additive effect on diameter expansion of the redo-THV, which remained constrained in most combinations. The only combination to achieve nominal expansion was the S3 in S3 when both pre- and post-dilatation were performed. The S3 remained underexpanded inside the SXT despite pre- and post-dilatation (93% in the mid-portion). Improved redo-THV expansion was accompanied by 2.7 mm (12%) overexpansion of the index THV. While all samples had acceptable hydrodynamic performance, the underexpanded samples had worse leaflet pinwheeling.
When performing redo-TAVI with a 23 mm S3 inside a 23 mm SXT or S3, only the S3 in S3 with the use of pre- and post-dilatation reached full expansion. This underlines the importance of CT assessment of THV expansion and the role of pre-/post-dilatation.
当选择球囊扩张型经导管心脏瓣膜(THV)来治疗失败的球囊扩张型 THV 时,存在扩张不足的风险,这可能会对性能产生影响。
我们旨在评估在 redo-经导管主动脉瓣置换术(TAVI)后预扩张和后扩张对球囊扩张型 THV 扩张的影响。
在 bench 上进行 redo-TAVI,将 23mm 的 SAPIEN 3(S3)植入 23mm 的 SAPIEN XT(SXT)或 23mm 的 S3 中,两者均作为“失败”的 THV。使用 23mm 非顺应性 TRUE 球囊进行预扩张和/或后扩张。在进行预-/后扩张之前和之后,使用 microCT(micro-CT)评估索引和 redo-THV 的扩张情况,并进行 THV 流体动力学测试。
在没有预扩张或后扩张的情况下,S3 在所有组合中都扩张不足,特别是在 THV 的中段(分别代表 SXT 和 S3 内部标称直径的 81%和 86%,为 18.6mm 和 19.7mm)。预扩张和后扩张对 redo-THV 的扩张具有附加作用,但在大多数组合中仍然受到限制。唯一达到标称扩张的组合是在 S3 中植入 S3 时同时进行预扩张和后扩张。尽管进行了预扩张和后扩张,但 S3 在 SXT 中仍扩张不足(中段为 93%)。redo-THV 扩张得到改善的同时,索引 THV 也出现了 2.7mm(12%)的过度扩张。虽然所有样本的流体动力学性能都可以接受,但扩张不足的样本瓣叶旋转较差。
在 23mm 的 SXT 或 S3 中植入 23mm 的 S3 进行 redo-TAVI 时,只有在使用预扩张和后扩张的情况下,S3 植入 S3 才能达到完全扩张。这强调了 CT 评估 THV 扩张的重要性和预扩张/后扩张的作用。